Lv1
90 积分 2024-08-19 加入
Patients with hepatocellular carcinoma with triple-positive tumor markers may benefit from postsurgery adjuvant treatment
5天前
已关闭
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones
9天前
已完结
An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment
11天前
已完结
CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma
24天前
已完结
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer
25天前
已完结
Kupffer cell calibration of T cell responses via VSIG4–CD5 interaction promotes tumor evasion
25天前
已完结
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization
26天前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
1个月前
已完结
Deep Survival Machines: Fully Parametric Survival Regression and Representation Learning for Censored Data With Competing Risks
1个月前
已完结
Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy
1个月前
已完结
皖公网安备34019202002308
